APA (7th ed.) Citation

Y, X., Y, W., Q, F., Y, Y., & Y, Z. (2026). The controversial role of metabolic reprogramming in anti-tumor therapy resistance. Discover oncology, 17(1), . https://doi.org/10.1007/s12672-026-04787-7

Chicago Style (17th ed.) Citation

Y, Xu, Wang Y, Fu Q, Yao Y, and Zhou Y. "The Controversial Role of Metabolic Reprogramming in Anti-tumor Therapy Resistance." Discover Oncology 17, no. 1 (2026). https://doi.org/10.1007/s12672-026-04787-7.

MLA (9th ed.) Citation

Y, Xu, et al. "The Controversial Role of Metabolic Reprogramming in Anti-tumor Therapy Resistance." Discover Oncology, vol. 17, no. 1, 2026, https://doi.org/10.1007/s12672-026-04787-7.